SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Frida Kahlo Synthetic CCD

PatientFrida Kahlo
Date of birth1989-07-06
IdentifiersMRN HR-NI011-SYN; SSN (made up) 000-11-4390
Document date2026-11-01
AuthorMarisol Ortega, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New primary care visit for chronic back, pelvic, and right leg pain on long-term opioid therapy. Concerns: Constant back and pelvic pain with burning in the right leg that limits how long she can stand and paint; Worried that her opioid dose will be cut suddenly and that the pain will become unbearable; Wants to keep teaching her students and painting every day. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day)One tablet by mouth every 6 hours as needed for pain; no more than 4 tablets a dayOral route2024-03-04 to 2026-10-15completedS
Oxycodone 10 mg oral tablet, one tablet three times daily as needed for painOne tablet by mouth three times daily as needed for painOral route2026-10-15activeS
Oxycodone 5 mg oral tablet, one tablet at bedtime as needed for painOne tablet by mouth at bedtime as needed for painOral route2026-10-15activeS
Duloxetine 30 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route2026-09-17 to 2026-10-01completedS
Duloxetine 60 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route2026-10-01activeS
Acetaminophen 500 mg oral tablet, two tablets three times dailyTwo tablets by mouth three times daily; no more than 3,000 mg a dayOral route2026-09-17activeS
Diclofenac sodium 1% topical gel, 2 g to the right ankle four times dailyApply 2 g to the right ankle and foot four times dailyTopical route2026-09-17activeS
Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet dailyOne tablet by mouth dailyOral route2026-09-17activeS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostrilFor suspected opioid overdose: one spray into one nostril and call 911; if there is no response after 2 to 3 minutes, give a second spray in the other nostrilNasal route2026-09-17activeS

Procedures

ProcedureDatesStatusEvidence
Plain X-ray of the right ankle: joint-space narrowing, osteophytes, and healed old fractures2026-09-17 to 2026-09-17completedS
Urine drug test, with consent, before continuing long-term opioid therapy; result consistent with the prescribed oxycodone only2026-09-17 to 2026-09-17completedS
Physical therapy twice weekly: graded exercise, core and hip strengthening, aquatic therapy, and a shoe lift for the shorter right leg2026-10-01in-progressS
Cognitive behavioral therapy for chronic pain, weekly2026-10-15in-progressS

Immunizations

DateVaccineStatusEvidence
2026-10-15Influenza vaccine, 2026-2027 seasoncompletedS
2022-02-14Tdap vaccinecompletedS
2026-10-22Hepatitis B vaccine, adjuvanted (HepB-CpG), dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1913Poliomyelitis at age six in 1913, leaving the right leg thinner, shorter, and less developed, with the foot turned outwardD (CLM-0003)
Proposed in 2006Congenital spinal anomaly (spina bifida) proposed retrospectively; not establishedR (CLM-0004)
September 17, 1925Bus and streetcar collision on September 17, 1925: pelvic fracture from a handrail injury through the hip, three spinal fractures, fractured collarbone and two ribs, dislocated right shoulder, and eleven fractures of the right leg with a dislocated footD (CLM-0005)
After 1925Many operations after the accident, some with long convalescences, and about 25 different corsets for postureD (CLM-0007)

Family History

RelativeConditionAge at deathEvidence
fatherEpilepsy; died in 1941, cause not recorded in the cited sourceD (CLM-0012)
motherDied in 1932; cause not recorded in the cited sourceD (CLM-0012)

Health Concerns

ConcernStatusEvidence
Constant back and pelvic pain with burning in the right leg that limits how long she can stand and paintactiveS
Worried that her opioid dose will be cut suddenly and that the pain will become unbearableactiveS
Wants to keep teaching her students and painting every dayactiveS

Assessment

Most recent measures: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-10-29; Creatinine [Mass/volume] in Serum or Plasma 0.72 on 2026-09-17; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 110 on 2026-09-17; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 18 on 2026-09-17; Mean score [PEG] 5.7 on 2026-10-22; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 2026-10-22; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 on 2026-10-22; Total score [AUDIT-C] 1 on 2026-10-22 [S]

Strengths and supports: Supports: spouse, a younger sister nearby, former students, and a wide circle of friends in the arts [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1925 injuriesactiveconfirmed G89.21S — Synthetic modern diagnosis linked to the documented injuries; the neuropathic interpretation is R.
Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocationactiveconfirmed M19.171S — Synthetic diagnosis confirmed on the synthetic ankle X-ray.
Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectivelyactiveprovisional B91S — Synthetic modern coding of the documented childhood diagnosis; the alternative remains R.
Long-term opioid therapy for chronic pain, 60 MME a day at intakeactiveconfirmed Z79.891S — Synthetic modern medication status; not a historical assertion.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic finding from the baseline 25-hydroxyvitamin D.
Acute viral upper respiratory infection (common cold), resolved without antibioticsresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-17Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
2026-09-17Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-09-17Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M110mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-09-1725-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma18ng/mL30-100 ng/mLLowS
2026-09-17Mean score [PEG]7.3{score}S
2026-09-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-10-01Mean score [PEG]7{score}S
2026-10-15Mean score [PEG]6{score}S
2026-10-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-10-29Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-35 U/LNormalS
2026-10-29Mean score [PEG]5.3{score}S
2026-10-29Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-08Mean score [PEG]7{score}S
2026-10-22Mean score [PEG]5.7{score}S
2026-10-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-10-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S
2026-10-22Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-09-17Body height160cmS
2026-09-17Body weight50kgS
2026-09-17Body mass index (BMI) [Ratio]19.5kg/m2S
2026-09-17Systolic blood pressure118mm[Hg]S
2026-09-17Diastolic blood pressure74mm[Hg]S
2026-09-17Heart rate82/minS
2026-09-17Respiratory rate14/minS
2026-09-17Body temperature36.7CelS
2026-09-17Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-01Body height160cmS
2026-10-01Body weight50kgS
2026-10-01Body mass index (BMI) [Ratio]19.5kg/m2S
2026-10-01Systolic blood pressure116mm[Hg]S
2026-10-01Diastolic blood pressure72mm[Hg]S
2026-10-01Heart rate80/minS
2026-10-01Respiratory rate14/minS
2026-10-01Body temperature36.6CelS
2026-10-01Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-15Body height160cmS
2026-10-15Body weight50.5kgS
2026-10-15Body mass index (BMI) [Ratio]19.7kg/m2S
2026-10-15Systolic blood pressure114mm[Hg]S
2026-10-15Diastolic blood pressure72mm[Hg]S
2026-10-15Heart rate78/minS
2026-10-15Respiratory rate14/minS
2026-10-15Body temperature36.7CelS
2026-10-15Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-29Body height160cmS
2026-10-29Body weight50.5kgS
2026-10-29Body mass index (BMI) [Ratio]19.7kg/m2S
2026-10-29Systolic blood pressure116mm[Hg]S
2026-10-29Diastolic blood pressure70mm[Hg]S
2026-10-29Heart rate76/minS
2026-10-29Respiratory rate14/minS
2026-10-29Body temperature36.6CelS
2026-10-29Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-08Body height160cmS
2026-10-08Body weight50kgS
2026-10-08Body mass index (BMI) [Ratio]19.5kg/m2S
2026-10-08Systolic blood pressure118mm[Hg]S
2026-10-08Diastolic blood pressure72mm[Hg]S
2026-10-08Heart rate88/minS
2026-10-08Respiratory rate16/minS
2026-10-08Body temperature37.6CelS
2026-10-08Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-22Body height160cmS
2026-10-22Body weight50.5kgS
2026-10-22Body mass index (BMI) [Ratio]19.7kg/m2S
2026-10-22Systolic blood pressure114mm[Hg]S
2026-10-22Diastolic blood pressure70mm[Hg]S
2026-10-22Heart rate76/minS
2026-10-22Respiratory rate14/minS
2026-10-22Body temperature36.6CelS
2026-10-22Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-09-17New primary care visit for chronic back, pelvic, and right leg pain on long-term opioid therapyfinishedS
2026-10-01Physical medicine and rehabilitation consultation for a multimodal rehabilitation planfinishedS
2026-10-15Four-week chronic pain follow-up with the first opioid dose reductionfinishedS
2026-10-29Six-week chronic pain review of function, mood, and the opioid taperfinishedS
2026-10-08Same-day sick visit for a common cold on long-term opioid therapyfinishedS
2026-10-22Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Physical medicine and rehabilitation referral for a multimodal rehabilitation plan: exercise therapy, bracing and orthotic review, a shoe lift for the leg-length difference, and function goalscompletedGL-VADOD-LBP-2022, GL-ACP-LBP-2017S
Nonopioid treatment first: duloxetine titrated to 60 mg daily, scheduled acetaminophen up to 3 g a day, and topical diclofenac for the anklecompletedGL-ACP-LBP-2017, GL-CDC-OPIOID-2022, GL-CMID-2026S
Opioid risk mitigation: review benefits and harms together, check the prescription drug monitoring program, urine drug test with consent, prescribe naloxone 4 mg nasal spray and teach a family member, and avoid benzodiazepines and other sedativescompletedGL-CDC-OPIOID-2022S
Collaborative, gradual opioid taper of about 10% of the dose a month, paused if pain or function worsens; never stop opioids abruptlycompletedGL-CDC-OPIOID-2022S
Physical therapy twice weekly with graded exercise and aquatic therapy, pain neuroscience education, and cognitive behavioral therapy for chronic paincompletedGL-ACP-LBP-2017, GL-VADOD-LBP-2022S
Measure pain and function with the PEG at every visit and depressive symptoms with the PHQ-9 every two to four weeks; complete a structured safety assessment if the PHQ-9 reaches 10 or item 9 is positivecompletedGL-CMID-2026, GL-CDC-OPIOID-2022S
Check ALT periodically on regular acetaminophen, and replete vitamin DcompletedGL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Improve the PEG score by at least 30% from baseline2026-10-29activePEG fell from 7.3 to 5.3 by the six-week review, a 27% improvement; goal continuedS
Stand at the easel for 30 minutes at a time by the six-week review2026-10-29completedStands 25 to 30 minutes at the easel with the shoe liftS
First opioid dose reduction, agreed by the patient, without loss of function2026-10-29completedReduced from 60 to 52.5 MME a day at the four-week visit; PEG and standing tolerance improved at the six-week reviewS
Naloxone in the home with a family member trained to use it2026-09-17completedNaloxone nasal spray dispensed; spouse taught at the first visitS

Functional Status

Mental Status